JOHNSON & JOHNSON 2033JOHNSON & JOHNSON 2033JOHNSON & JOHNSON 2033

JOHNSON & JOHNSON 2033

No trades
See on Supercharts

Key terms


Outstanding amount
‪850.00 M‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
4.38% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
4.82%
Maturity date
Dec 5, 2033
Term to maturity
8 years

About JOHNSON & JOHNSON 2033


Sector
Health Technology
Home page
Issue date
Dec 5, 2013
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.